Treating Vasculitis with Rituximab
Links shared publicly online about this topic
Rituximab in ANCA-Associated Vasculitis: Fad or Fact
content.karger.com — “Rituximab in ANCA-Associated Vasculitis: Fad or Fact” View full resource at content.karger.com
Most Recently Shared on December 16, 2010 at 4:15 pm By:
Urology & Nephrology OW Health
Rituximab in ANCA-Associated Vasculitis: Fad or Fact: Nephron Clin Pract 2011;118:c182–c188 (DOI:10.1159/00032... http://bit.ly/gqE4pR
Scientists Author Editorial On International Trials For Vasculitis
medicalnewstoday.com — “Two UNC School of Medicine faculty authored an editorial in the July 15, 2010 New England Journal of Medicine commenting on results from two clinical trials using the drug Rituximab to trea” View full resource at medicalnewstoday.com
Most Recently Shared on July 15, 2010 at 3:07 pm By:
Scientists Author Editorial On International Trials For Vasculitis http://mnt.to/3G84 #vaccines #immunesystem
Medical News: ACR: Rituximab Equals Standard Treatment for Vasculitis - in Meeting Coverage, ACR from MedPage Today
medpagetoday.com — “PHILADELPHIA -- Rituximab (Rituxan) and cyclophosphamide were equally effective in inducing remission in patients with severe ANCA-associated vasculitis, researchers reported here.” View full resource at medpagetoday.com
Most Recently Shared on October 20, 2009 at 12:47 pm By:
Rituximab equals cyclophosphamide for inducing remission in patients with severe ANCA-associated vasculitis http://bit.ly/NmXo8 #acr09
Rheumatology Article | Vasculitis
mdlinx.com — “Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis” View full resource at mdlinx.com
Most Recently Shared on April 5, 2011 at 2:53 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitis: Clinica... http://bit.ly/hgWMqc #Rheumatology
Rheumatology Article | Vasculitis
mdlinx.com — “Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis” View full resource at mdlinx.com
Most Recently Shared on May 27, 2011 at 6:36 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculit... http://bit.ly/iEZ5l8 #Rheumatology
Oncology Article | Vasculitis Cytoplasm
mdlinx.com — “Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: Follow-up data from European Vasculitis Study Group clinical trials” View full resource at mdlinx.com
Most Recently Shared on June 22, 2011 at 9:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculiti... http://bit.ly/iuAZGa #oncology
Rheumatology Article | Vasculitis
mdlinx.com — “Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides” View full resource at mdlinx.com
Most Recently Shared on February 21, 2011 at 8:33 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with syst... http://bit.ly/dLtaun #Rheumatology
Rituximab versus Cyclophosphamide for ANCA-associated vasculitis: A review of RAVE and RITUXIVAS Trials : Nephrology On-Demand
blog.ecu.edu — “Rituximab versus Cyclophosphamide for ANCA-associated vasculitis: A review of RAVE and RITUXIVAS Trials : Nephrology On-Demand” View full resource at blog.ecu.edu
Most Recently Shared on August 16, 2011 at 7:05 pm By:
Nephrology On-Demand Medical Journal and Nephrology
Rituximab v. Cyclophosphamide for ANCA+ vasculitis: review of RAVE & RITUXIVAS http://t.co/EhShRKP #medstudents #kidney #renal #nephrology
Short-Course Rituximab Produces Long-Term Remissions of ANCA Vasculitis - Renal and Urology News
renalandurologynews.com — “PRAGUE—A single four-week course of rituximab was as effective as 18 months of standard therapy with daily oral cyclophosphamide (CyP) and azathioprine (AZA) for induction and maintenance of remission in patients with severe anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). For either treatment, the number, rate, and severity of adverse events did not differ.” View full resource at renalandurologynews.com
Most Recently Shared on June 27, 2011 at 1:18 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Short-Course Rituximab Produces Long-Term Remissions of ANCA Vasculitis: PRAGUE—A single four-week course of rit... http://bit.ly/ik5CcB
Leukocytoclastic Vasculitis: eMedicine Rheumatology
emedicine.medscape.com — “Overview: Leukocytoclastic vasculitis (LCV), also known as hypersensitivity vasculitis and hypersensitivity angiitis, is a histopathologic term commonly used to denote a small-vessel vasculitis (see image shown below). Leukocytoclastic vasculitis has many causes, but no cause is identified ...” View full resource at emedicine.medscape.com
Most Recently Shared on September 24, 2010 at 9:52 pm By:
Rituximab bests cyclophosphamide in ANCA-associated vasculitis. See the eMedicine topic Leukocytoclastic Vasculitis. http://bit.ly/c1tqpF
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com
latimes.com — “Forty years after the development of the only therapy for vasculitis, a rare but severe disease of blood vessels, researchers have found a new therapy that is at least as effective, requires fewer treatments and promises far fewer side effects. Federally-funded researchers reported Wednesday that treatment with the biotech drug rituximab, already marketed as Rituxan for the treatment of B cell lymphoma and rheumatoid arthritis, is slightly more effective than the existing drug, cyclophosphamide,” View full resource at latimes.com
Most Recently Shared on July 15, 2010 at 8:20 pm By:
Monica R.Gaidhane Doctor and Physician
New vasculitis therapy: Researchers find new therapy for vasculitis - latimes.com http://bit.ly/aHnDxU
Avoiding Infertility And Cancer With New Therapy For Vasculitis
medicalnewstoday.com — “Researchers have identified that rituxan, a drug previously approved for the treatment of non-hodgkin's b cell lymphoma and rheumatoid arthritis, can treat severe anca-associated vasculitis as eff” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2009 at 11:39 am By:
Avoiding Infertility And Cancer With New Therapy For Vasculitis: Researchers have identified that Rituxan, a dru.. http://bit.ly/3zU0EY
Rheumatology News & Articles - MDLinx - Vasculitis on #MDlinx
mdlinx.com — “Rheumatology News & Articles - MDLinx - Vasculitis on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on July 21, 2010 at 6:14 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis: New England Journal of Medicine http://bit.ly/aXBrxc #Rheumatology
Rho Contributes to a Major Advance in Treating Severe Form of Vasculitis - Drugs.com MedNews
drugs.com — “Chapel Hill, NC June 8, 2011 Investigators in the Immune Tolerance Network (ITN), an international consortium supported by the National Institute of Allergy and” View full resource at drugs.com
Most Recently Shared on June 8, 2011 at 6:17 pm By:
Drugs and Devices OW OW Health
Rho Contributes to a Major Advance in Treating Severe Form of Vasculitis: Chapel Hill, NC – <June 8, 2011>... http://bit.ly/l45E8B #drug
Rituxan Gains Indication for Severe Vasculitis - MPR
empr.com — “The FDA has approved Rituxan (rituximab; Genentech) in combination with corticosteroids for the treatment of adults with Wegener--™s granulomatosis and microscopic polyangiitis, two forms of severe ANCA-associated vasculitis.” View full resource at empr.com
Most Recently Shared on April 20, 2011 at 2:16 pm By:
MPR News: Rituxan Gains Indication for Severe Vasculitis: The FDA has approved Rituxan (rituximab; Genentech) in... http://bit.ly/hHmGuo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Urology & Nephrology
Organizing urology resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Vaccines
The latest immune system and vaccines news published daily. Articles from research centers, universities and prestigious journals.
-
MedPage Today
Daily, peer reviewed medical news for clinicians
Advertisement
